Hemostasis Using Radiofrequency Ablation for Track Bleeding

  • STATUS
    Recruiting
  • End date
    Dec 31, 2024
  • participants needed
    10
  • sponsor
    Kyoung Doo Song
Updated on 30 August 2021
haemostasis

Summary

This study aims to evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding that has occurred after percutaneous biopsy of the liver.

Description

Purpose: To evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding after percutaneous liver biopsy.

Method
  • Enroll patients who continue to bleed despite conservative treatment for track bleeding that has occurred after liver biopsy.
  • Radiofreqeuncy ablation: Under monitoring vital signs and controlling pain with intravenous agents, the electrode is inserted into the bleeding focus. The bleeding focus is ablated.
  • Hemostasis is evaluated by ultrasound (right after radiofrequency ablation), CT scan (after the radiofrequency ablation), and ultrasound (the day after radiofrequency ablation)
  • If hemostasis fails using radiofrequency ablation, transarterial hepatic embolization is performed immediately.

Details
Condition Hemorrhage
Treatment Radiofrequency ablation
Clinical Study IdentifierNCT05017350
SponsorKyoung Doo Song
Last Modified on30 August 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Ultrasound guided percutaneous liver biopsy at Samsung Medical Center
Track bleeding after biopsy
Persistent track bleeding even after conservative management
Consent to this study

Exclusion Criteria

Not consent to this study
<20 years old or >=80 years old
Contraindication to radiofrequency ablation
Radiofrequency ablation for track bleeding is not technically possible
Unstable vital signs
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note